alpha-eudesmol has been researched along with Cerebral Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, Y; Asakura, K; Kagawa, K; Kanemasa, T; Kihara, T; Matsuo, Y; Minagawa, K; Ninomiya, M; Oshima, T | 1 |
1 other study(ies) available for alpha-eudesmol and Cerebral Infarction
| Article | Year |
|---|---|
omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats.
Topics: Animals; Brain Edema; Brain Ischemia; Calcium Channel Blockers; Cerebral Infarction; Dose-Response Relationship, Drug; Glutamic Acid; Male; Neuroprotective Agents; omega-Agatoxin IVA; Potassium; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sesquiterpenes, Eudesmane; Terpenes | 2000 |